✦ LIBER ✦

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)

✍ Scribed by James E Wraith; Lorne A Clarke; Michael Beck; Edwin H Kolodny; Gregory M Pastores; Joseph Muenzer; David M Rapoport; Kenneth I Berger; Stuart J Swiedler; Emil D Kakkis; Tanja Braakman; Elenie Chadbourne; Karen Walton-Bowen; Gerald F Cox

Book ID: 116682587
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 224 KB
Volume: 144
Category: Article
ISSN: 1097-6833
DOI: 10.1016/j.jpeds.2004.01.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzyme Replacement Therapy in Patients W

Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human -L-Iduronidase (Laronidase)

✍ Wraith, J. Edmond (author);Beck, Michael (author);Lane, Roderick (author);Van De 📂 Article 📅 2007 🏛 American Academy of Pediatrics 🌐 English ⚖ 408 KB

Enzyme Replacement Therapy in Patients W

Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human -L-Iduronidase (Laronidase)

✍ Wraith, J. Edmond (author);Beck, Michael (author);Lane, Roderick (author);Van De 📂 Article 📅 2007 🏛 American Academy of Pediatrics 🌐 English ⚖ 408 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

✍ Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Enzyme replacement therapy for mucopolys

✍ Paul Harmatz; Roberto Giugliani; Ida Schwartz; Nathalie Guffon; Elisa Leão Teles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of recombinant human α-interferon therapy for chronic non-A, non-B (type C) hepatitis

✍ Di Bisceglie, A.M.; Martin, P.; Kassianides, C.; Goodman, Z.; Lisker-Melman, M.; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views